Rituximab
Composition
Contains Rituximab, a chimeric monoclonal antibody targeting CD20 on B-cells.
Indications
Used for non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and some autoimmune diseases.
Side effects
Infusion reactions, infections, neutropenia, fever, rash, hypotension.
Precautions
Premedicate to reduce infusion reactions; monitor for infections and hepatitis B reactivation.
Contraindications
Hypersensitivity to rituximab or murine proteins, active severe infections.
Dosage and administration
Administered by intravenous infusion; dosing varies by indication
Countries
Available Forms
Injectable solution for intravenous infusion.